TP53 and neoplasm: In most of the tumors this gene get mutated, CRISPR shows a promising results in CRISPR/Cas 9 induced double strand breaks in p53 gene tumor suppressor interactome [49] and homologous recombination with functional cDNA to sustain p53 expression and tumor regression [50].